Rekah Pharmaceutical Industry Ltd Strategic Asset Allocation Index
Rekah Pharmaceutical Industry Ltd strategic asset allocation index. Rekah Pharmaceutical Industry Ltd (REKA) has a Strategic Asset Allocation Index of 94.8% as of June 2023. Strategic assets (PP&E of ILA153.37 Million plus long-term investments of ILA-) total ILA153.37 Million, measured against net assets of ILA161.84 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Rekah Pharmaceutical Industry Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Rekah Pharmaceutical Industry Ltd (2004–2021)
Strategic asset allocation index of Rekah Pharmaceutical Industry Ltd from 2004 to 2021. This chart shows how Rekah Pharmaceutical Industry Ltd's Strategic Asset Allocation Index has evolved across 18 annual periods from 2004 to 2021. As of June 2023, the index stands at 94.8%, representing strategic assets of ILA153.37 Million against net assets of ILA161.84 Million ILA. Check tangible equity quality of Rekah Pharmaceutical Industry Ltd to evaluate the tangible quality of the company's equity base.
Rekah Pharmaceutical Industry Ltd Strategic Asset Allocation Index by Year (2004–2021)
Rekah Pharmaceutical Industry Ltd strategic asset allocation index by year from 2004 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Rekah Pharmaceutical Industry Ltd from 2004 to 2021, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see REKA stock market capitalisation.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 102.3% | ILA177.00 Million | ILA177.00 Million | ILA- | ILA173.06 Million | ▼ -7.5 pp |
| 2020 | 109.8% | ILA181.82 Million | ILA181.82 Million | ILA- | ILA165.59 Million | ▼ -6.8 pp |
| 2019 | 116.6% | ILA181.02 Million | ILA181.02 Million | ILA- | ILA155.22 Million | ▲ +52.0 pp |
| 2018 | 64.7% | ILA97.43 Million | ILA97.43 Million | ILA- | ILA150.66 Million | ▼ -1.9 pp |
| 2017 | 66.6% | ILA96.28 Million | ILA96.28 Million | ILA- | ILA144.62 Million | ▼ -17.1 pp |
| 2016 | 83.7% | ILA88.56 Million | ILA88.56 Million | ILA- | ILA105.86 Million | ▲ +13.3 pp |
| 2015 | 70.4% | ILA87.01 Million | ILA86.40 Million | ILA610.00K | ILA123.66 Million | ▼ -36.1 pp |
| 2014 | 106.5% | ILA82.05 Million | ILA82.05 Million | ILA- | ILA77.06 Million | ▲ +18.6 pp |
| 2013 | 87.9% | ILA69.89 Million | ILA69.89 Million | ILA- | ILA79.51 Million | ▼ -13.7 pp |
| 2012 | 101.6% | ILA72.30 Million | ILA72.30 Million | ILA- | ILA71.17 Million | ▼ -5.9 pp |
| 2011 | 107.5% | ILA68.82 Million | ILA68.82 Million | ILA- | ILA64.00 Million | ▲ +0.4 pp |
| 2010 | 107.1% | ILA68.31 Million | ILA68.31 Million | ILA- | ILA63.78 Million | ▲ +3.1 pp |
| 2009 | 104.0% | ILA66.74 Million | ILA66.74 Million | ILA- | ILA64.15 Million | ▼ -0.8 pp |
| 2008 | 104.9% | ILA61.48 Million | ILA61.48 Million | ILA- | ILA58.62 Million | ▲ +21.1 pp |
| 2007 | 83.8% | ILA56.24 Million | ILA56.24 Million | ILA- | ILA67.10 Million | ▼ -10.5 pp |
| 2006 | 94.3% | ILA58.03 Million | ILA58.03 Million | ILA- | ILA61.54 Million | ▲ +18.5 pp |
| 2005 | 75.8% | ILA44.62 Million | ILA44.62 Million | ILA- | ILA58.85 Million | ▼ -12.2 pp |
| 2004 | 88.1% | ILA43.03 Million | ILA43.03 Million | ILA- | ILA48.86 Million | — |